Prognostic value of C-reactive protein as an inflammatory and n-terminal probrain natriuretic peptide as a neurohumoral marker in acute heart failure (from the Korean heart failure registry)

American Journal of Cardiology

Volumn 113, Issue 3, 2014, Pages 511-517

  Park, Jin Joo ^a   Choi, Dong Ju ^a   Yoon, Chang Hwan ^a   Oh, Il Young ^a   Jeon, Eun Seok ^b   Kim, Jae Joong ^c   Cho, Myeong Chan ^d   Chae, Shung Chull ^e   Ryu, Kyu Hyung ^f   Yoo, Byung Su ^g   Kang, Seok Min ^h   Oh, Byung Hee ⁱ  

^a Seoul National University Bundang Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Chungbuk National University College of Medicine   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

^f Konkuk University Hospital   (South Korea)

^g Yonsei University Wonju   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

ⁱ Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ACUTE HEART FAILURE; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; FOLLOW UP; HUMAN; KOREA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; UNIVERSITY HOSPITAL;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; INPATIENTS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84892583993     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.10.022     Document Type: Article

References (31)

1. R.W. Schrier, and W.T. Abraham Hormones and hemodynamics in heart failure N Engl J Med 341 1999 577 585
2. S.R. Goldsmith, G.S. Francis, and A.W. Cowley Jr. Arginine vasopressin and the renal response to water loading in congestive heart failure Am J Cardiol 58 1986 295 299
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators N Engl J Med 325 1991 293 302
4. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
5. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, and J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
6. B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241
7. R. Sharma, A.J. Coats, and S.D. Anker The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1 Int J Cardiol 72 2000 175 186
8. R.S. Vasan, L.M. Sullivan, R. Roubenoff, C.A. Dinarello, T. Harris, E.J. Benjamin, D.B. Sawyer, D. Levy, P.W. Wilson, and R.B. D'Agostino Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study Circulation 107 2003 1486 1491
9. J.N. Cohn, T.B. Levine, M.T. Olivari, V. Garberg, D. Lura, G.S. Francis, A.B. Simon, and T. Rector Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 1984 819 823
10. W.H. Lee, and M. Packer Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure Circulation 73 1986 257 267
11. K. Maeda, T. Tsutamoto, A. Wada, T. Hisanaga, and M. Kinoshita Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825 832
12. F. Bursi, S.A. Weston, M.M. Redfield, S.J. Jacobsen, S. Pakhomov, V.T. Nkomo, R.A. Meverden, and V.L. Roger Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
13. M. Gheorghiade, W.T. Abraham, N.M. Albert, W. Gattis Stough, B.H. Greenberg, C.M. O'Connor, L. She, C.W. Yancy, J. Young, G.C. Fonarow, and Investigators O-H, Coordinators Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry Eur Heart J 28 2007 980 988
14. L. Klein, C.M. O'Connor, J.D. Leimberger, W. Gattis-Stough, I.L. Piña, G.M. Felker, K.F. Adams Jr., R.M. Califf, M. Gheorghiade, and OPTIME-CHF Investigators Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study Circulation 111 2005 2454 2460
15. D.E. Forman, J. Butler, Y. Wang, W.T. Abraham, C.M. O'Connor, S.S. Gottlieb, E. Loh, B.M. Massie, M.W. Rich, L.W. Stevenson, J.B. Young, and H.M. Krumholz Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure J Am Coll Cardiol 43 2004 61 67
16. W.H. Yin, J.W. Chen, H.L. Jen, M.C. Chiang, W.P. Huang, A.N. Feng, M.S. Young, and S.J. Lin Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure Am Heart J 147 2004 931 938
17. J.D. Windram, P.H. Loh, A.S. Rigby, I. Hanning, A.L. Clark, and J.G. Cleland Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure Am Heart J 153 2007 1048 1055
18. J.L. Januzzi, R. van Kimmenade, J. Lainchbury, A. Bayes-Genis, J. Ordonez-Llanos, M. Santalo-Bel, Y.M. Pinto, and M. Richards NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
19. Y. Seino, A. Ogawa, T. Yamashita, M. Fukushima, K. Ogata, H. Fukumoto, and T. Takano Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure Eur J Heart Fail 6 2004 295 300
20. S.A. Hunt, and American College of C, American Heart Association Task Force on Practice G ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 46 2005 e1 82
21. S.P. Collins, C.J. Lindsell, C.A. Jenkins, F.E. Harrell, G.J. Fermann, K.F. Miller, S.N. Roll, M.I. Sperling, D.J. Maron, A.J. Naftilan, J.A. McPherson, N.L. Weintraub, D.B. Sawyer, and A.B. Storrow Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies Am Heart J 164 2012 825 834
22. D.J. Choi, S. Han, E.S. Jeon, M.C. Cho, J.J. Kim, B.S. Yoo, M.S. Shin, I.W. Seong, Y. Ahn, S.M. Kang, Y.J. Kim, H.S. Kim, S.C. Chae, B.H. Oh, M.M. Lee, and K.H. Ryu Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean Heart Failure registry Korean Circ J 41 2011 363 371
23. K.K. Ho, K.M. Anderson, W.B. Kannel, W. Grossman, and D. Levy Survival after the onset of congestive heart failure in Framingham Heart Study subjects Circulation 88 1993 107 115
24. P.M. Ridker C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus J Am Coll Cardiol 49 2007 2129 2138
25. J.E. Volanakis Human C-reactive protein: expression, structure, and function Mol Immunol 38 2001 189 197
26. C. Toniatti, R. Arcone, B. Majello, U. Ganter, G. Arpaia, and G. Ciliberto Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer Mol Biol Med 7 1990 199 212
27. C. Toniatti, A. Demartis, P. Monaci, A. Nicosia, and G. Ciliberto Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites EMBO J 9 1990 4467 4475
28. P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., J.J. Kastelein, W. Koenig, P. Libby, A.J. Lorenzatti, J.G. MacFadyen, B.G. Nordestgaard, J. Shepherd, J.T. Willerson, R.J. Glynn, and JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
29. J.J. Park, H.J. Jang, I.Y. Oh, C.H. Yoon, J.W. Suh, Y.S. Cho, T.J. Youn, G.Y. Cho, I.H. Chae, and D.J. Choi Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention Am J Cardiol 111 2013 636 642
30. B. Stanek, B. Frey, M. Hülsmann, R. Berger, B. Sturm, J. Strametz-Juranek, J. Bergler-Klein, P. Moser, A. Bojic, E. Hartter, and R. Pacher Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction J Am Coll Cardiol 38 2001 436 442
31. I.S. Anand, L.D. Fisher, Y.T. Chiang, R. Latini, S. Masson, A.P. Maggioni, R.D. Glazer, G. Tognoni, J.N. Cohn, and Val-HeFT Investigators Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 2003 1278 1283